tiprankstipranks

David Stump Insider Profile

4 Followers
David Stump, Director at Viracta Therapeutics, holds 0.00 shares in Viracta Therapeutics (Ticker: VIRX), holds 11.29K shares in RegenXBio (Ticker: RGNX), holds 4.50K shares in MacroGenics (Ticker: MGNX). Most recently, David Stump ― shares of Viracta Therapeutics on ― for an estimated value of ―.
tipranks
David Stump

David Stump
Viracta Therapeutics (VIRX)
Director

Not Ranked
David Stump has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$164K
86.51%
13.49%
0.00%
A breakdown of David Stump's holdings

Insider Roles

RegenXBio
(RGNX)
Director
MacroGenics
(MGNX)
Director
Viracta Therapeutics
(VIRX)
Director
Roles that David Stump holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by David Stump

David Stump's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Viracta Therapeutics
Director
$0.00
RegenXBio
Jun 04, 2024
Director
Uninformative Buy
$141.98K
PTLA
Portola Pharma
Jul 02, 2020
Uninformative Sell
237.49K
$0.00
MacroGenics
May 22, 2024
Director
Uninformative Buy
19.17K
$22.14K
DNDNQ
Dendreon Corp
Jan 07, 2014
Uninformative Buy
List of latest transactions for each holding click on a transaction to see David Stump's performance on stock

David Stump insider profile FAQ

What is the percentage of profitable transactions made by David Stump?
The percentage of profitable transactions made by David Stump is ―.
    What is the average return per transaction made by David Stump?
    The average return per transaction made by David Stump is ―.
      What stocks does David Stump hold?
      David Stump holds: VIRX, RGNX, PTLA, MGNX, DNDNQ stocks.
        What was David Stump’s latest transaction?
        David Stump latest transaction was an Uninformative Buy of ―.
          What was David Stump's most profitable transaction?
          David Stump’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is David Stump's role in Viracta Therapeutics?
            David Stump's role in Viracta Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.